[癌症后的不那么密集的随访通常同样有效]
Julien A M Vos1,2, Hidde Swartjes3, Dirk J Grünhagen4
1Amsterdam UMC, afd. Huisartsgeneeskunde, Amsterdam.
Nederlands tijdschrift voor geneeskunde
|September 26, 2024
概括
密集的癌症随访可能并不总是必要的. 减少一些癌症的检查频率,如乳腺癌和结肠直肠癌,对生存率或患者满意度没有负面影响.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 癌症的生存率 癌症的生存率
背景情况:
- 癌症后的随访通常涉及定期检查,以早期发现复发和后续护理.
- 密集的后续策略是大多数癌症类型的标准建议.
研究的目的:
- 评估所有癌症类型的密集后续战略的必要性.
- 调查减少随访频率对患者结果和满意度的影响.
主要方法:
- 审查目前对各种癌症类型的随访指南.
- 对生存数据和患者满意度指标的分析,以应对不同的随访频率.
- 对乳腺癌和结直肠癌结局的比较分析,随着减少的随访时间表.
主要成果:
- 减少某些癌症 (例如乳腺癌,结直肠癌) 的随访频率并没有对存活率产生不利影响 (HR 1.05;95% CI:0.96-1.14).
- 患者满意度不受这些癌症类型的随访强度下降的影响.
- 具有良好的预后的癌症可能会有效地容忍不那么密集的随访.
结论:
- 不那么密集的随访策略对于具有良好的预后的癌症也同样有效.
- 基于个人需求的个性化后续计划是可行的.
- 目前的后续指导方针需要进行批判性重新评估,以优化护理和资源分配.
相关概念视频
01:21Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K